A study published in the journal Expert Review of Neurotherapeutics, and published online by the National Institute of Health, has found promising evidence that cannabinoids can provide a natural treatment for the symptoms of multiple sclerosis.
“In an experimental mouse model of MS-related spasticity, Sativex [a product made entirely from cannabis] dose-dependently improved hind limb flexion/stiffness and a dosage of 10 mg/kg was shown to be as [or more] effective as the most widely established anti-spasticity treatment baclofen (5 mg/kg)”, claims the study.
According to researchers at the Institute of Biomolecular Chemistry at Consiglio Nazionale delle Ricerche in Italy; “These findings with Sativex are very promising and offer encouragement for MS patients, the majority of whom will develop spasticity-related disabling and recalcitrant symptoms. Furthermore, research into the endocannabinoid system may offer potential in other neurodegenerative, inflammatory and pain disorders.”
The study can be found by clicking here.